1. Home
  2. SLB vs BSX Comparison

SLB vs BSX Comparison

Compare SLB & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Schlumberger N.V.

SLB

Schlumberger N.V.

HOLD

Current Price

$51.91

Market Cap

78.1B

Sector

Energy

ML Signal

HOLD

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

HOLD

Current Price

$43.56

Market Cap

68.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLB
BSX
Founded
1926
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
78.1B
68.0B
IPO Year
1996
2010

Fundamental Metrics

Financial Performance
Metric
SLB
BSX
Price
$51.91
$43.56
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
19
22
Target Price
$57.85
$93.18
AVG Volume (30 Days)
12.2M
18.5M
Earning Date
04-24-2026
04-22-2026
Dividend Yield
2.12%
N/A
EPS Growth
N/A
55.20
EPS
1.02
1.51
Revenue
$30,440,000,000.00
$9,076,000,000.00
Revenue This Year
$3.91
$11.85
Revenue Next Year
$6.20
$10.16
P/E Ratio
$50.75
$28.95
Revenue Growth
9.46
12.49
52 Week Low
$31.64
$42.20
52 Week High
$60.46
$105.65

Technical Indicators

Market Signals
Indicator
SLB
BSX
Relative Strength Index (RSI) 43.34 39.31
Support Level $51.74 $42.43
Resistance Level $52.69 $46.37
Average True Range (ATR) 1.92 1.40
MACD -0.80 -0.30
Stochastic Oscillator 17.83 13.54

Price Performance

Historical Comparison
SLB
BSX

About SLB Schlumberger N.V.

SLB is the world's premier oilfield-services company as measured by market share. While the industry is largely fragmented, SLB holds the first or second competitive position in many of the differentiated oligopolies in which it operates. Also known as Schlumberger, the company was founded in 1926 by Conrad and Marcel Schlumberger. Today, it's most known as a global industry leader in innovation, while it focuses its strategy on its three growth engines: core, digital, and new energy businesses. Over three-fourths of its revenue base is tied to international markets, while the company boasts nearly $3 billion in digital-related revenue.

About BSX Boston Scientific Corporation

Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Share on Social Networks: